| Year |
Citation |
Score |
| 2023 |
Agin-Liebes J, Hickman RA, Vonsattel JP, Faust PL, Flowers X, Utkina Sosunova I, Ntiri J, Mayeux R, Surface M, Marder K, Fahn S, Przedborski S, Alcalay RN. Patterns of TDP-43 Deposition in Brains with LRRK2 G2019S Mutations. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37218402 DOI: 10.1002/mds.29449 |
0.573 |
|
| 2023 |
Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, et al. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36692014 DOI: 10.1002/mds.29288 |
0.503 |
|
| 2021 |
Williams L, Olszewska DA, Fearon C, Magennis B, McCarthy A, Rowland LP, Mayeux R, Page R, Fahn S, Beausang A, Lynch T. Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by Variants. Movement Disorders Clinical Practice. 8: 954-958. PMID 34405105 DOI: 10.1002/mdc3.13265 |
0.715 |
|
| 2021 |
McRae C, Dunk M, Russell D, Ellgring H, Stern Y, Greene P, Fahn S, Henchcliffe C. Baseline Differences in Long-term Survivors and Nonsurvivors of the Colorado/Columbia Fetal Implant Trial. Journal of the International Neuropsychological Society : Jins. 1-8. PMID 34121635 DOI: 10.1017/S1355617721000680 |
0.383 |
|
| 2020 |
Yu E, Rudakou U, Krohn L, Mufti K, Ruskey JA, Asayesh F, Estiar MA, Spiegelman D, Surface M, Fahn S, Waters CH, Greenbaum L, Espay AJ, Dauvilliers Y, Dupré N, et al. Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32970363 DOI: 10.1002/mds.28299 |
0.313 |
|
| 2019 |
Alcalay RN, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu RYJ, Ruskey JA, Leblond CS, Ambalavanan A, Laurent SB, Spiegelman D, Dionne-Laporte A, Liong C, Levy OA, Fahn S, et al. SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30788890 DOI: 10.1002/Mds.27642 |
0.566 |
|
| 2018 |
Merchant SH, Vial F, Leodori G, Fahn S, Pullman SL, Hallett M. A novel exaggerated "spino-bulbo-spinal like" reflex of lower brainstem origin. Parkinsonism & Related Disorders. PMID 30316728 DOI: 10.1016/j.parkreldis.2018.10.007 |
0.555 |
|
| 2018 |
Shah H, Liong C, Levy OA, Waters C, Fahn S, Marder K, Kang UJ, Wolf P, Oliva P, Zhang K, Alcalay RN, Gutierrez J. Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation: A Pilot Study. Stroke. PMID 29986930 DOI: 10.1161/Strokeaha.118.021964 |
0.377 |
|
| 2018 |
Ruskey JA, Greenbaum L, Roncière L, Alam A, Spiegelman D, Liong C, Levy OA, Waters C, Fahn S, Marder KS, Chung W, Yahalom G, Israeli-Korn S, Livneh V, Fay-Karmon T, et al. Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease. European Journal of Medical Genetics. PMID 29842932 DOI: 10.1016/j.ejmg.2018.05.005 |
0.494 |
|
| 2018 |
Isaacson SH, Fahn S, Pahwa R, Tanner CM, Espay AJ, Trenkwalder C, Adler CH, Patni R, Johnson R. Parkinson's Patients with Dyskinesia Switched from Immediate Release Amantadine to Open-label ADS-5102. Movement Disorders Clinical Practice. 5: 183-190. PMID 29780852 DOI: 10.1002/mdc3.12595 |
0.342 |
|
| 2017 |
Martelli D, Luo L, Kang J, Kang UJ, Fahn S, Agrawal SK. Adaptation of Stability during Perturbed Walking in Parkinson's Disease. Scientific Reports. 7: 17875. PMID 29259237 DOI: 10.1038/S41598-017-18075-6 |
0.367 |
|
| 2017 |
Fahn S. The 200-year journey of Parkinson disease: Reflecting on the past and looking towards the future. Parkinsonism & Related Disorders. PMID 28784297 DOI: 10.1016/j.parkreldis.2017.07.020 |
0.385 |
|
| 2016 |
Alcalay RN, Levy OA, Wolf P, Oliva P, Zhang XK, Waters CH, Fahn S, Kang U, Liong C, Ford B, Mazzoni P, Kuo S, Johnson A, Xiong L, Rouleau GA, et al. SCARB2 variants and glucocerebrosidase activity in Parkinson's disease. Npj Parkinson's Disease. 2. PMID 27110593 DOI: 10.1038/Npjparkd.2016.4 |
0.631 |
|
| 2015 |
Sulzer D, Chaudhuri KR, Fahn S. Introducing a new journal on Parkinson's disease. Npj Parkinson's Disease. 1: 15006. PMID 28725680 DOI: 10.1038/npjparkd.2015.6 |
0.364 |
|
| 2015 |
Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, ... ... Fahn S, et al. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. Jama Neurology. 1-9. PMID 26569098 DOI: 10.1001/Jamaneurol.2015.2736 |
0.403 |
|
| 2015 |
McCarthy A, Lonergan R, Olszewska DA, O'Dowd S, Cummins G, Magennis B, Fallon EM, Pender N, Huey ED, Cosentino S, O'Rourke K, Kelly BD, O'Connell M, Delon I, Farrell M, ... ... Fahn S, et al. Closing the tau loop: the missing tau mutation. Brain : a Journal of Neurology. PMID 26297556 DOI: 10.1093/Brain/Awv234 |
0.687 |
|
| 2015 |
Virmani T, Moskowitz CB, Vonsattel JP, Fahn S. Clinicopathological characteristics of freezing of gait in autopsy-confirmed Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26234730 DOI: 10.1002/Mds.26346 |
0.721 |
|
| 2015 |
Robakis D, Fahn S. Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease. Cns Drugs. 29: 433-41. PMID 26164425 DOI: 10.1007/s40263-015-0249-8 |
0.314 |
|
| 2015 |
Alcalay RN, Levy OA, Waters CC, Fahn S, Ford B, Kuo SH, Mazzoni P, Pauciulo MW, Nichols WC, Gan-Or Z, Rouleau GA, Chung WK, Wolf P, Oliva P, Keutzer J, et al. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Brain : a Journal of Neurology. PMID 26117366 DOI: 10.1093/Brain/Awv179 |
0.654 |
|
| 2015 |
Clark LN, Chan R, Cheng R, Liu X, Park N, Parmalee N, Kisselev S, Cortes E, Torres PA, Pastores GM, Vonsattel JP, Alcalay R, Marder K, Honig LL, Fahn S, et al. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease. Plos One. 10: e0125204. PMID 25933391 DOI: 10.1371/Journal.Pone.0125204 |
0.64 |
|
| 2015 |
Gan-Or Z, Alcalay RN, Bar-Shira A, Leblond CS, Postuma RB, Ben-Shachar S, Waters C, Johnson A, Levy O, Mirelman A, Gana-Weisz M, Dupré N, Montplaisir J, Giladi N, Fahn S, et al. Genetic markers of Restless Legs Syndrome in Parkinson disease. Parkinsonism & Related Disorders. 21: 582-5. PMID 25817513 DOI: 10.1016/J.Parkreldis.2015.03.010 |
0.389 |
|
| 2015 |
Kestenbaum M, Fahn S. Safety of IPX066 , an extended release carbidopa-levodopa formulation, for the treatment of Parkinson's disease. Expert Opinion On Drug Safety. 14: 761-7. PMID 25697185 DOI: 10.1517/14740338.2015.1015986 |
0.381 |
|
| 2015 |
Fahn S. The medical treatment of Parkinson disease from James Parkinson to George Cotzias. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 4-18. PMID 25491387 DOI: 10.1002/mds.26102 |
0.398 |
|
| 2015 |
Fahn S, Poewe W. Levodopa: 50 years of a revolutionary drug for Parkinson disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1-3. PMID 25488146 DOI: 10.1002/mds.26122 |
0.341 |
|
| 2015 |
Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, et al. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 278-83. PMID 25393808 DOI: 10.1002/Mds.26065 |
0.539 |
|
| 2015 |
Alcalay RN, Mejia-Santana H, Mirelman A, Saunders-Pullman R, Raymond D, Palmese C, Caccappolo E, Ozelius L, Orr-Urtreger A, Clark L, Giladi N, Bressman S, Marder K, Tang MX, Santana HM, ... ... Fahn S, et al. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease Parkinsonism and Related Disorders. 21: 106-110. DOI: 10.1016/j.parkreldis.2014.09.033 |
0.644 |
|
| 2014 |
Simon KC, Eberly S, Gao X, Oakes D, Tanner CM, Shoulson I, Fahn S, Schwarzschild MA, Ascherio A. Mendelian randomization of serum urate and parkinson disease progression. Annals of Neurology. 76: 862-8. PMID 25257975 DOI: 10.1002/Ana.24281 |
0.378 |
|
| 2014 |
Arkadir D, Bergman H, Fahn S. Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease. Neurology. 82: 1093-8. PMID 24663231 DOI: 10.1212/WNL.0000000000000243 |
0.331 |
|
| 2014 |
Tanner CM, Meng CC, Ravina B, Lang A, Kurlan R, Marek K, Oakes D, Seibyl J, Flagg E, Gauger L, Guest DD, Goetz CG, Kieburtz K, DiEuliis D, Fahn S, et al. A practical approach to remote longitudinal follow-up of Parkinson's disease: the FOUND study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 743-9. PMID 24515275 DOI: 10.1002/Mds.25814 |
0.407 |
|
| 2014 |
Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella CL, Nance MA, Bressman SB, Scott WK, Tanner CM, Mickel SF, Waters CH, ... Fahn S, et al. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. Jama Neurology. 71: 62-7. PMID 24190026 DOI: 10.1001/Jamaneurol.2013.4498 |
0.559 |
|
| 2014 |
Pahwa R, Lyons KE, Hauser RA, Fahn S, Jankovic J, Pourcher E, Hsu A, O'Connell M, Kell S, Gupta S. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. Parkinsonism & Related Disorders. 20: 142-8. PMID 24055014 DOI: 10.1016/j.parkreldis.2013.08.017 |
0.382 |
|
| 2014 |
Dinur T, Quinn T, Sakanaka K, Levy O, Marder KS, Waters C, Fahn S, Dorovski T, Pauciulo M, Nichols W, Rana HQ, Balwani M, Bier L, Elstein D, Zimran A, et al. Parkinson disease penetrance in patients with Gaucher disease and in glucocerebrosidase mutation carriers Molecular Genetics and Metabolism. 111: S37-S38. DOI: 10.1016/j.ymgme.2013.12.071 |
0.492 |
|
| 2013 |
Alcalay RN, Mirelman A, Saunders-Pullman R, Tang MX, Mejia Santana H, Raymond D, Roos E, Orbe-Reilly M, Gurevich T, Bar Shira A, Gana Weisz M, Yasinovsky K, Zalis M, Thaler A, Deik A, ... ... Fahn S, et al. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1966-71. PMID 24243757 DOI: 10.1002/Mds.25647 |
0.702 |
|
| 2013 |
Mirelman A, Heman T, Yasinovsky K, Thaler A, Gurevich T, Marder K, Bressman S, Bar-Shira A, Orr-Urtreger A, Giladi N, Hausdorff JM, Saunders-Pullman R, Shanker VL, Groves M, Palmese C, ... ... Fahn S, et al. Fall risk and gait in Parkinson's disease: The role of the LRRK2 G2019S mutation Movement Disorders. 28: 1683-1690. PMID 24123150 DOI: 10.1002/Mds.25587 |
0.674 |
|
| 2013 |
Liu X, Cheng R, Ye X, Verbitsky M, Kisselev S, Mejia-Santana H, Louis E, Cote L, Andrews H, Waters C, Ford B, Fahn S, Marder K, Lee J, Clark L. Increased Rate of Sporadic and Recurrent Rare Genic Copy Number Variants in Parkinson's Disease Among Ashkenazi Jews. Molecular Genetics & Genomic Medicine. 1: 142-154. PMID 24073418 DOI: 10.1002/Mgg3.18 |
0.543 |
|
| 2012 |
Poston KL, Tang CC, Eckert T, Dhawan V, Frucht S, Vonsattel JP, Fahn S, Eidelberg D. Network correlates of disease severity in multiple system atrophy. Neurology. 78: 1237-44. PMID 22491861 DOI: 10.1212/WNL.0b013e318250d7fd |
0.384 |
|
| 2012 |
Alcalay RN, Caccappolo E, Mejia-Santana H, Tang M-, Rosado L, Orbe Reilly M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Fahn S, et al. Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology. 78: 1434-40. PMID 22442429 DOI: 10.1212/Wnl.0B013E318253D54B |
0.541 |
|
| 2012 |
Poulopoulos M, Cortes E, Vonsattel JP, Fahn S, Waters C, Cote LJ, Moskowitz C, Honig LS, Clark LN, Marder KS, Alcalay RN. Clinical and pathological characteristics of LRRK2 G2019S patients with PD. Journal of Molecular Neuroscience : Mn. 47: 139-43. PMID 22194196 DOI: 10.1007/S12031-011-9696-Y |
0.566 |
|
| 2012 |
Lees A, Fahn S, Eggert KM, Jankovic J, Lang A, Micheli F, Mouradian MM, Oertel WH, Olanow CW, Poewe W, Rascol O, Tolosa E, Squillacote D, Kumar D. Perampanel, an AMPA antagonist, found to have no benefit in reducing "off" time in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 284-8. PMID 22161845 DOI: 10.1002/mds.23983 |
0.311 |
|
| 2012 |
Caccappolo E, Alcalay R, Marder K, Tang M, Rosado L, Mejia-Santana H, Ruiz D, Orbe-Reilly M, Ross B, Verbitsky M, Kisselev S, Louis E, Colcher A, Comella C, Siderowf A, ... ... Fahn S, et al. The Effect of Parkin Mutation Status on Cognitive Functioning in EOPD Patients with Long Disease Duration: The CORE-PD Study (PD7.008) Neurology. 78: PD7.008-PD7.008. DOI: 10.1212/wnl.78.1_meetingabstracts.pd7.008 |
0.492 |
|
| 2012 |
Alcalay R, Rosado L, Mejia-Santana H, Orbe-Reilly M, Caccappolo E, Tang M, Ruiz D, Ross B, Verbitsky M, Kisselev S, Louis E, Comella C, Colcher A, Jennings D, Nance M, ... ... Fahn S, et al. Clinical and Genetic Characteristics of Participants with Juvenile PD: The CORE-PD Study (IN10-2.001) Neurology. 78: IN10-2.001-IN10-2.00. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In10-2.001 |
0.534 |
|
| 2011 |
Srivastava A, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Caccappolo E, Comella C, Colcher A, Siderowf A, Jennings D, Nance M, Bressman S, Scott WK, Tanner C, Mickel S, ... ... Fahn S, et al. The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism & Related Disorders. 17: 740-4. PMID 21856206 DOI: 10.1016/J.Parkreldis.2011.07.008 |
0.501 |
|
| 2011 |
Liu X, Cheng R, Verbitsky M, Kisselev S, Browne A, Mejia-Sanatana H, Louis ED, Cote LJ, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Marder K, Clark LN, et al. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. Bmc Medical Genetics. 12: 104. PMID 21812969 DOI: 10.1186/1471-2350-12-104 |
0.516 |
|
| 2011 |
Alcalay RN, Siderowf A, Ottman R, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Louis E, Ruiz D, Waters C, Fahn S, Cote L, Frucht S, Ford B, Orbe-Reilly M, et al. Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology. 76: 319-26. PMID 21205674 DOI: 10.1212/Wnl.0B013E31820882Aa |
0.552 |
|
| 2011 |
Caccappolo E, Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, ... ... Fahn S, et al. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. Journal of the International Neuropsychological Society : Jins. 17: 91-100. PMID 21092386 DOI: 10.1017/S1355617710001190 |
0.557 |
|
| 2010 |
Alcalay RN, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Ross BM, Verbitsky M, Kisselev S, Louis ED, Comella C, Colcher A, Jennings D, Nance MA, Bressman SB, Scott WK, ... ... Fahn S, et al. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Archives of Neurology. 67: 1116-22. PMID 20837857 DOI: 10.1001/Archneurol.2010.194 |
0.573 |
|
| 2010 |
Gilbert RM, Fahn S, Mitsumoto H, Rowland LP. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1868-75. PMID 20669307 DOI: 10.1002/mds.23200 |
0.633 |
|
| 2010 |
Marder KS, Tang MX, Mejia-Santana H, Rosado L, Louis ED, Comella CL, Colcher A, Siderowf AD, Jennings D, Nance MA, Bressman S, Scott WK, Tanner CM, Mickel SF, Andrews HF, ... ... Fahn S, et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Archives of Neurology. 67: 731-8. PMID 20558392 DOI: 10.1001/Archneurol.2010.95 |
0.552 |
|
| 2010 |
Fahn S. Parkinson's disease: 10 years of progress, 1997-2007. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S2-14. PMID 20187239 DOI: 10.1002/mds.22796 |
0.409 |
|
| 2010 |
Fahn S, Marder K, Côté L. Frontiers of science and clinical advances in quality of life in Parkinson's disease. Preface. Movement Disorders : Official Journal of the Movement Disorder Society. 25: S1. PMID 20187233 DOI: 10.1002/Mds.23029 |
0.505 |
|
| 2010 |
Alcalay RN, Mejia-Santana H, Tang MX, Rakitin B, Rosado L, Ross B, Verbitsky M, Kisselev S, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, ... ... Fahn S, et al. Self-report of cognitive impairment and mini-mental state examination performance in PRKN, LRRK2, and GBA carriers with early onset Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 32: 775-9. PMID 20182943 DOI: 10.1080/13803390903521018 |
0.491 |
|
| 2010 |
Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. The Lancet. Neurology. 9: 149-58. PMID 20061183 DOI: 10.1016/S1474-4422(10)70002-8 |
0.348 |
|
| 2009 |
Alcalay RN, Mejia-Santana H, Tang MX, Rosado L, Verbitsky M, Kisselev S, Ross BM, Louis ED, Comella CL, Colcher A, Jennings D, Nance MA, Bressman S, Scott WK, Tanner C, ... ... Fahn S, et al. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Archives of Neurology. 66: 1517-22. PMID 20008657 DOI: 10.1001/Archneurol.2009.267 |
0.561 |
|
| 2009 |
Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, Bar-Shira A, Berg D, Bras J, Brice A, Chen CM, Clark LN, Condroyer C, De Marco EV, Dürr A, ... ... Fahn S, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. The New England Journal of Medicine. 361: 1651-61. PMID 19846850 DOI: 10.1056/Nejmoa0901281 |
0.541 |
|
| 2009 |
Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, ... ... Fahn S, et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Archives of Neurology. 66: 1460-8. PMID 19822770 DOI: 10.1001/Archneurol.2009.247 |
0.345 |
|
| 2009 |
Ravina B, Tanner C, Dieuliis D, Eberly S, Flagg E, Galpern WR, Fahn S, Goetz CG, Grate S, Kurlan R, Lang AE, Marek K, Kieburtz K, Oakes D, Elliott R, et al. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 2081-90. PMID 19691116 DOI: 10.1002/Mds.22690 |
0.376 |
|
| 2009 |
Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisselev S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K. Association of glucocerebrosidase mutations with dementia with lewy bodies. Archives of Neurology. 66: 578-83. PMID 19433657 DOI: 10.1001/Archneurol.2009.54 |
0.637 |
|
| 2008 |
Fahn S. How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both? Annals of Neurology. 64: S56-64. PMID 19127577 DOI: 10.1002/ana.21453 |
0.33 |
|
| 2008 |
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 2129-70. PMID 19025984 DOI: 10.1002/Mds.22340 |
0.345 |
|
| 2008 |
Fahn S. The history of dopamine and levodopa in the treatment of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: S497-508. PMID 18781671 DOI: 10.1002/mds.22028 |
0.385 |
|
| 2008 |
Schifitto G, Friedman JH, Oakes D, Shulman L, Comella CL, Marek K, Fahn S. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology. 71: 481-5. PMID 18695158 DOI: 10.1212/01.Wnl.0000324862.29733.69 |
0.372 |
|
| 2008 |
Wang Y, Clark LN, Louis ED, Mejia-Santana H, Harris J, Cote LJ, Waters C, Andrews H, Ford B, Frucht S, Fahn S, Ottman R, Rabinowitz D, Marder K. Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Archives of Neurology. 65: 467-74. PMID 18413468 DOI: 10.1001/Archneur.65.4.467 |
0.561 |
|
| 2008 |
Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, Leurgans S. Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 690-9. PMID 18228568 DOI: 10.1002/Mds.21894 |
0.38 |
|
| 2007 |
McClelland S, Vonsattel JP, Garcia RE, Amaya MD, Winfield LM, Pullman SL, Yu Q, Fahn S, Ford B, Goodman RR. Relationship of clinical efficacy to postmortem-determined anatomic subthalamic stimulation in Parkinson syndrome. Clinical Neuropathology. 26: 267-75. PMID 18232592 DOI: 10.5414/Npp26267 |
0.63 |
|
| 2007 |
Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology. 69: 1270-7. PMID 17875915 DOI: 10.1212/01.Wnl.0000276989.17578.02 |
0.567 |
|
| 2007 |
Clark LN, Haamer E, Mejia-Santana H, Harris J, Lesage S, Durr A, Bs SJ, Hedrich K, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, et al. Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 932-7. PMID 17415800 DOI: 10.1002/Mds.21419 |
0.563 |
|
| 2007 |
Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 68: 812-9. PMID 17353469 DOI: 10.1212/01.Wnl.0000256715.13907.D3 |
0.379 |
|
| 2007 |
Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 41-7. PMID 17115387 DOI: 10.1002/mds.21198 |
0.349 |
|
| 2006 |
Clark LN, Wang Y, Karlins E, Saito L, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology. 67: 1786-91. PMID 17050822 DOI: 10.1212/01.Wnl.0000244345.49809.36 |
0.561 |
|
| 2006 |
Clark LN, Afridi S, Karlins E, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K. Case-control study of the parkin gene in early-onset Parkinson disease. Archives of Neurology. 63: 548-52. PMID 16606767 DOI: 10.1001/Archneur.63.4.548 |
0.56 |
|
| 2006 |
Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, et al. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Archives of Neurology. 63: 210-6. PMID 16476809 DOI: 10.1001/Archneur.63.2.210 |
0.375 |
|
| 2005 |
Fahn S. Does levodopa slow or hasten the rate of progression of Parkinson's disease? Journal of Neurology. 252: IV37-IV42. PMID 16222436 DOI: 10.1007/s00415-005-4008-5 |
0.395 |
|
| 2005 |
Levy G, Louis ED, Cote L, Perez M, Mejia-Santana H, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Marder K. Contribution of aging to the severity of different motor signs in Parkinson disease. Archives of Neurology. 62: 467-72. PMID 15767513 DOI: 10.1001/Archneur.62.3.467 |
0.556 |
|
| 2005 |
Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 64: 208-15. PMID 15668415 DOI: 10.1212/01.Wnl.0000149403.14458.7F |
0.329 |
|
| 2005 |
Clark LN, Nicolai A, Afridi S, Harris J, Mejia-Santana H, Strug L, Cote LJ, Louis ED, Andrews H, Waters C, Ford B, Frucht S, Fahn S, Mayeux R, Ottman R, et al. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 100-3. PMID 15517591 DOI: 10.1002/Mds.20320 |
0.687 |
|
| 2004 |
Fahn S, Sulzer D. Neurodegeneration and neuroprotection in Parkinson disease. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 1: 139-54. PMID 15717014 DOI: 10.1602/neurorx.1.1.139 |
0.396 |
|
| 2004 |
Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K. Levodopa and the progression of Parkinson's disease. The New England Journal of Medicine. 351: 2498-508. PMID 15590952 DOI: 10.1056/Nejmoa033447 |
0.36 |
|
| 2004 |
Fahn S. ALS lessons learned from other neurological diseases. Parkinson's disease. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 26-30. PMID 15512865 DOI: 10.1080/17434470410019852 |
0.329 |
|
| 2004 |
Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, et al. Huntington's Disease-like 2 (HDL2) in North America and Japan. Annals of Neurology. 56: 670-4. PMID 15468075 DOI: 10.1002/Ana.20248 |
0.349 |
|
| 2004 |
Ford B, Winfield L, Pullman SL, Frucht SJ, Du Y, Greene P, Cheringal JH, Yu Q, Cote LJ, Fahn S, McKhann GM, Goodman RR. Subthalamic nucleus stimulation in advanced Parkinson's disease: blinded assessments at one year follow up. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1255-9. PMID 15314110 DOI: 10.1136/jnnp.2003.027557 |
0.636 |
|
| 2004 |
Gordon PH, Fahn S, Chin S, Golbe LI, Lynch T, Eidelberg D. Woman with a 26-year history of parkinsonism, supranuclear ophthalmoplegia, and loss of postural reflexes. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 950-61. PMID 15300663 DOI: 10.1002/Mds.20139 |
0.426 |
|
| 2004 |
Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Archives of Neurology. 61: 1044-53. PMID 15262734 DOI: 10.1001/Archneur.61.7.1044 |
0.376 |
|
| 2004 |
Levy G, Louis ED, Mejia-Santana H, Côté L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Lack of familial aggregation of Parkinson disease and Alzheimer disease. Archives of Neurology. 61: 1033-9. PMID 15262733 DOI: 10.1001/Archneur.61.7.1033 |
0.553 |
|
| 2004 |
Clark LN, Afridi S, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Singleton A, Wavrant De-Vrieze F, Hardy J, Mayeux R, Fahn S, Waters C, Ford B, Frucht S, et al. Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 796-800. PMID 15254937 DOI: 10.1002/Mds.20131 |
0.672 |
|
| 2004 |
Gordon PH, Yu Q, Qualls C, Winfield H, Dillon S, Greene PE, Fahn S, Breeze RE, Freed CR, Pullman SL. Reaction time and movement time after embryonic cell implantation in Parkinson disease. Archives of Neurology. 61: 858-61. PMID 15210522 DOI: 10.1001/Archneur.61.6.858 |
0.637 |
|
| 2004 |
Munhoz RP, Li JY, Kurtinecz M, Piboolnurak P, Constantino A, Fahn S, Lang AE. Evaluation of the pull test technique in assessing postural instability in Parkinson's disease. Neurology. 62: 125-7. PMID 14718714 DOI: 10.1212/Wnl.62.1.125 |
0.354 |
|
| 2004 |
Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O'Hearn E, Ross CA, Seltzer WK, Walker RH, Ashizawa T, Rasmussen A, Hayden M, Almqvist EW, Harris J, Fahn S, MacDonald ME, et al. Erratum: Huntington's disease-like 2 (HDL2) in North America and Japan (Annals of Neurology (November 2004) 56 (670-674)) Annals of Neurology. 56. DOI: 10.1002/Ana.20349 |
0.323 |
|
| 2003 |
Rosenberg RN, Pedley TA, Baringer JR, Fahn S, Lisak RP, Mayeux RP, Olson SF, Ringel SP, Rowland LP, Selzer ME. At jeopardy: the NIH as we know it. Neurorehabilitation and Neural Repair. 17: 203-5. PMID 14677215 DOI: 10.1177/0888439003259700 |
0.709 |
|
| 2003 |
Louis ED, Levy G, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R, Marder K. Risk of action tremor in relatives of tremor-dominant and postural instability gait disorder PD. Neurology. 61: 931-6. PMID 14557562 DOI: 10.1212/Wnl.61.7.931 |
0.538 |
|
| 2003 |
Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Familial aggregation of early- and late-onset Parkinson's disease. Annals of Neurology. 54: 507-13. PMID 14520664 DOI: 10.1002/Ana.10711 |
0.538 |
|
| 2003 |
Rosenberg RN, Pedley TA, Baringer JR, Fahn S, Lisak RP, Mayeux RP, Olson SF, Ringel SP, Rowland LP, Selzer ME. At jeopardy: the NIH as we know it. Archives of Neurology. 60: 1191-2. PMID 12975281 DOI: 10.1001/archneur.60.9.1191 |
0.709 |
|
| 2003 |
Marder K, Levy G, Louis ED, Mejia-Santana H, Cote L, Andrews H, Harris J, Waters C, Ford B, Frucht S, Fahn S, Ottman R. Accuracy of family history data on Parkinson's disease. Neurology. 61: 18-23. PMID 12847150 DOI: 10.1212/01.Wnl.0000074784.35961.C0 |
0.534 |
|
| 2003 |
Trott CT, Fahn S, Greene P, Dillon S, Winfield H, Winfield L, Kao R, Eidelberg D, Freed CR, Breeze RE, Stern Y. Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study. Neurology. 60: 1938-43. PMID 12821736 DOI: 10.1212/01.Wnl.0000070181.28651.3B |
0.475 |
|
| 2002 |
Greene PE, Fahn S. Status of fetal tissue transplantation for the treatment of advanced Parkinson disease. Neurosurgical Focus. 13: e3. PMID 15769072 DOI: 10.3171/Foc.2002.13.5.4 |
0.356 |
|
| 2002 |
Gordon PH, Pullman SL, Louis ED, Frucht SJ, Fahn S. Mirtazapine in Parkinsonian tremor. Parkinsonism & Related Disorders. 9: 125-6. PMID 12473405 DOI: 10.1016/S1353-8020(02)00011-1 |
0.627 |
|
| 2002 |
Siderowf A, Stern M, Shoulson I, Kieburtz K, Oakes D, Day D, Shinaman A, Plumb S, Fahn S, Blindauer K, Lew M, Hurtig H, Lloyd M, Hauser R, Gauger L, et al. A controlled trial of rasagiline in early Parkinson disease: The tempo study Archives of Neurology. 59: 1937-1943. PMID 12470183 DOI: 10.1001/Archneur.59.12.1937 |
0.379 |
|
| 2002 |
Kock N, Müller B, Vieregge P, Pramstaller PP, Marder K, Abbruzzese G, Martinelli P, Lang AE, Jacobs H, Hagenah J, Harris J, Meija-Santana H, Fahn S, Hedrich K, Kann M, et al. Role of SCA2 mutations in early- and late-onset dopa-responsive parkinsonism. Annals of Neurology. 52: 257-8; author reply . PMID 12210804 DOI: 10.1002/Ana.10270 |
0.512 |
|
| 2002 |
Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. Movement Disorders : Official Journal of the Movement Disorder Society. 17: 513-7. PMID 12112199 DOI: 10.1002/Mds.10119 |
0.572 |
|
| 2002 |
Hedrich K, Marder K, Harris J, Kann M, Lynch T, Meija-Santana H, Pramstaller PP, Schwinger E, Bressman SB, Fahn S, Klein C. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology. 58: 1239-46. PMID 11971093 DOI: 10.1212/Wnl.58.8.1239 |
0.621 |
|
| 2002 |
Pedley TA, Swift TR, Miller A, Fahn S. Pharmaceutical industry support of the AAN Annual Meeting: policies and violation. Neurology. 58: 519-21. PMID 11865126 DOI: 10.1212/Wnl.58.4.519 |
0.611 |
|
| 2001 |
Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S, Mayeux R, Rowland LP, Wilhelmsen KC. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994. Neurology. 57: S39-45. PMID 11775599 |
0.716 |
|
| 2001 |
Louis ED, Levy G, Côte LJ, Mejia H, Fahn S, Marder K. Clinical correlates of action tremor in Parkinson disease. Archives of Neurology. 58: 1630-4. PMID 11594921 DOI: 10.1001/Archneur.58.10.1630 |
0.576 |
|
| 2001 |
Nakamura T, Dhawan V, Chaly T, Fukuda M, Ma Y, Breeze R, Greene P, Fahn S, Freed C, Eidelberg D. Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease. Annals of Neurology. 50: 181-7. PMID 11506400 DOI: 10.1002/Ana.1075 |
0.342 |
|
| 2001 |
Giladi N, McDermott MP, Fahn S, Przedborski S, Jankovic J, Stern M, Tanner C. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology. 56: 1712-21. PMID 11425939 DOI: 10.1212/Wnl.56.12.1712 |
0.342 |
|
| 2001 |
Louis ED, Winfield L, Fahn S, Ford B. Speech dysfluency exacerbated by levodopa in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 562-5. PMID 11391759 DOI: 10.1002/Mds.1081 |
0.392 |
|
| 2001 |
Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. The New England Journal of Medicine. 344: 710-9. PMID 11236774 DOI: 10.1056/Nejm200103083441002 |
0.332 |
|
| 2000 |
Thyagarajan D, Bressman S, Bruno C, Przedborski S, Shanske S, Lynch T, Fahn S, DiMauro S. A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Annals of Neurology. 48: 730-6. PMID 11079536 DOI: 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0 |
0.401 |
|
| 2000 |
Bressman SB, Sabatti C, Raymond D, de Leon D, Klein C, Kramer PL, Brin MF, Fahn S, Breakefield X, Ozelius LJ, Risch NJ. The DYT1 phenotype and guidelines for diagnostic testing. Neurology. 54: 1746-52. PMID 10802779 DOI: 10.1212/Wnl.54.9.1746 |
0.305 |
|
| 2000 |
Furukawa Y, Hornykiewicz O, Fahn S, Kish SJ. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology. 54: 1193-5. PMID 10720299 DOI: 10.1212/Wnl.54.5.1193 |
0.338 |
|
| 1999 |
Agid Y, Ahlskog E, Albanese A, Calne D, Chase T, De Yebenes J, Factor S, Fahn S, Gershanik O, Goetz C, Koller W, Kurth M, Lang A, Lees A, Lewitt P, et al. Levodopa in the treatment of Parkinson's disease: a consensus meeting. Movement Disorders : Official Journal of the Movement Disorder Society. 14: 911-3. PMID 10584663 DOI: 10.1002/1531-8257(199911)14:6<911::Aid-Mds1001>3.0.Co;2-H |
0.381 |
|
| 1999 |
Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology. 52: 1908-10. PMID 10371546 DOI: 10.1212/Wnl.52.9.1908 |
0.328 |
|
| 1999 |
Fahn S. Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA. Archives of Neurology. 56: 529-35. PMID 10328247 DOI: 10.1001/Archneur.56.5.529 |
0.405 |
|
| 1999 |
Saunders-Pullman R, Gordon-Elliott J, Parides M, Fahn S, Saunders HR, Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology. 52: 1417-21. PMID 10227628 DOI: 10.1212/Wnl.52.7.1417 |
0.366 |
|
| 1998 |
Lieberman A, Olanow CW, Sethi K, Swanson P, Waters CH, Fahn S, Hurtig H, Yahr M. A multicenter trial of ropinirole as adjunct treatment for Parkinson's disease. Ropinirole Study Group. Neurology. 51: 1057-62. PMID 9781529 DOI: 10.1212/WNL.51.4.1057 |
0.377 |
|
| 1998 |
Fahn S, Clarence-Smith KE, Chase TN. Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 759-67. PMID 9756143 DOI: 10.1002/Mds.870130502 |
0.343 |
|
| 1998 |
Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, ... ... Fahn S, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393: 702-5. PMID 9641683 DOI: 10.1038/31508 |
0.502 |
|
| 1998 |
Fahn S. Tolcapone: COMT inhibition for the treatment of Parkinson's disease. Neurology. 50: S1-2. PMID 9591515 DOI: 10.1212/Wnl.50.5_Suppl_5.S1 |
0.399 |
|
| 1998 |
Dauer WT, Burke RE, Greene P, Fahn S. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain : a Journal of Neurology. 121: 547-60. PMID 9577384 DOI: 10.1093/brain/121.4.547 |
0.331 |
|
| 1997 |
Chouinard S, Louis ED, Fahn S. Agreement among movement disorder specialists on the clinical diagnosis of essential tremor. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 973-6. PMID 9399223 DOI: 10.1002/Mds.870120621 |
0.305 |
|
| 1997 |
Lynch T, Fahn S, Louis ED, Odel JG. Oculofacial-skeletal myorhythmia in Whipple's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 12: 625-6. PMID 9251096 |
0.456 |
|
| 1997 |
Lynch T, Odel J, Fredericks DN, Louis ED, Forman S, Rotterdam H, Fahn S, Relman DA. Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease. Annals of Neurology. 42: 120-4. PMID 9225695 DOI: 10.1002/Ana.410420120 |
0.511 |
|
| 1997 |
Bressman SB, de Leon D, Raymond D, Greene PE, Brin MF, Fahn S, Ozelius LJ, Breakefield XO, Kramer PL, Risch NJ. Secondary dystonia and the DYTI gene. Neurology. 48: 1571-7. PMID 9191768 DOI: 10.1212/WNL.48.6.1571 |
0.305 |
|
| 1997 |
Louis ED, Ottman R, Ford B, Pullman S, Martinez M, Fahn S, Hauser WA. The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology. 16: 124-33. PMID 9159767 DOI: 10.1159/000109681 |
0.518 |
|
| 1997 |
Fahn S. An overview of novel therapies for Parkinson's disease. Experimental Neurology. 144: 21-3. PMID 9126146 DOI: 10.1006/exnr.1996.6382 |
0.354 |
|
| 1997 |
Louis ED, Klatka LA, Liu Y, Fahn S. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology. 48: 376-80. PMID 9040725 DOI: 10.1212/Wnl.48.2.376 |
0.396 |
|
| 1996 |
Olanow CW, Fahn S, Langston JW, Godbold J. Selegiline and mortality in Parkinson's disease. Annals of Neurology. 40: 841-5. PMID 9007088 DOI: 10.1002/ana.410400605 |
0.335 |
|
| 1996 |
Fahn S. Is levodopa toxic? Neurology. 47: S184-95. PMID 8959987 DOI: 10.1212/Wnl.47.6_Suppl_3.184S |
0.389 |
|
| 1996 |
Pullman SL, Greene P, Fahn S, Pedersen SF. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Archives of Neurology. 53: 617-24. PMID 8929169 DOI: 10.1001/Archneur.1996.00550070055012 |
0.589 |
|
| 1996 |
Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Annals of Neurology. 40: 561-8. PMID 8871574 DOI: 10.1002/Ana.410400404 |
0.533 |
|
| 1996 |
Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 214-6. PMID 8684394 DOI: 10.1002/mds.870110216 |
0.368 |
|
| 1996 |
Louis ED, Lynch T, Marder K, Fahn S. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 185-92. PMID 8684390 DOI: 10.1002/Mds.870110212 |
0.607 |
|
| 1996 |
Louis ED, Lynch T, Ford B, Greene P, Bressman SB, Fahn S. Delayed-onset cerebellar syndrome. Archives of Neurology. 53: 450-4. PMID 8624221 DOI: 10.1001/Archneur.1996.00550050080027 |
0.517 |
|
| 1996 |
Pullman SL, Ford B, Elibol B, Uncini A, Su PC, Fahn S. Cutaneous electromyographic silent period findings in brachial dystonia. Neurology. 46: 503-8. PMID 8614522 DOI: 10.1212/Wnl.46.2.503 |
0.651 |
|
| 1996 |
Fahn S. Book Review The Case of the Frozen Addicts: How the solution of an extraordinary medical mystery spawned a revolution in the understanding and treatment of Parkinson's disease By J. William Langston and Jon Palfreman. 309 pp. New York, Pantheon, 1996. $25. 0-679-42465-2 The New England Journal of Medicine. 335: 2002-2003. DOI: 10.1056/Nejm199612263352618 |
0.316 |
|
| 1995 |
Ford B, Fahn S, Pullman SL. Peripherally induced EMG silent periods. Normal physiology and disorders of motor control. Advances in Neurology. 67: 321-8. PMID 8848978 |
0.555 |
|
| 1995 |
Louis ED, Lynch T, Cargan AL, Fahn S. Generalized chorea in an infant with semilobar holoprosencephaly. Pediatric Neurology. 13: 355-7. PMID 8771177 DOI: 10.1016/0887-8994(95)00221-9 |
0.486 |
|
| 1995 |
Stewart C, Winfield L, Hunt A, Bressman SB, Fahn S, Blitzer A, Brin MF. Speech dysfunction in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 562-5. PMID 8552106 DOI: 10.1002/mds.870100506 |
0.369 |
|
| 1995 |
McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW. Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Archives of Neurology. 52: 565-70. PMID 7763203 DOI: 10.1001/Archneur.1995.00540300037010 |
0.394 |
|
| 1995 |
Louis ED, Goldman JE, Powers JM, Fahn S. Parkinsonian features of eight pathologically diagnosed cases of diffuse Lewy body disease. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 188-94. PMID 7753061 DOI: 10.1002/Mds.870100209 |
0.398 |
|
| 1995 |
Przedborski S, Jackson-Lewis V, Fahn S. Antiparkinsonian therapies and brain mitochondrial complex I activity. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 312-7. PMID 7651449 DOI: 10.1002/Mds.870100314 |
0.323 |
|
| 1995 |
Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the unified Parkinson's disease rating scale. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 263-6. PMID 7544438 DOI: 10.1002/mds.870100305 |
0.305 |
|
| 1994 |
Lynch T, Burke RE, Fahn S. Progress in psychiatry. The New England Journal of Medicine. 330: 285-6. PMID 8272093 |
0.395 |
|
| 1994 |
Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 40-7. PMID 8139604 DOI: 10.1002/Mds.870090107 |
0.36 |
|
| 1994 |
Przedborski S, Giladi N, Takikawa S, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, Fahn S, Eidelberg D. Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome. Neurology. 44: 1622-8. PMID 7936286 DOI: 10.1212/Wnl.44.9.1622 |
0.312 |
|
| 1994 |
Fahn S, Mayeux R, Rowland LP. A new eponym: Wilhelmsen-Lynch disease. Neurology. 44: 1980. PMID 7936262 DOI: 10.1212/WNL.44.10.1980 |
0.69 |
|
| 1994 |
Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF, Sima AA, Keohane C, Nygaard TG, Fahn S. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 44: 1878-84. PMID 7936241 DOI: 10.1212/Wnl.44.10.1878 |
0.625 |
|
| 1994 |
Pullman SL, Elibol B, Fahn S. Modulation of parkinsonian tremor by radial nerve palsy. Neurology. 44: 1861-4. PMID 7936237 DOI: 10.1212/Wnl.44.10.1861 |
0.621 |
|
| 1993 |
Dwork AJ, Balmaceda C, Fazzini EA, MacCollin M, Côté L, Fahn S. Dominantly inherited, early-onset parkinsonism: neuropathology of a new form. Neurology. 43: 69-74. PMID 8423914 DOI: 10.1212/WNL.43.1_Part_1.69 |
0.348 |
|
| 1993 |
Przedborski S, Jackson-Lewis V, Muthane U, Jiang H, Ferreira M, Naini AB, Fahn S. Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Annals of Neurology. 34: 715-23. PMID 8239566 DOI: 10.1002/Ana.410340515 |
0.354 |
|
| 1992 |
Giladi N, McMahon D, Przedborski S, Flaster E, Guillory S, Kostic V, Fahn S. Motor blocks in Parkinson's disease. Neurology. 42: 333-9. PMID 1736161 DOI: 10.1212/Wnl.42.2.333 |
0.41 |
|
| 1992 |
Fahn S. Fetal-tissue transplants in Parkinson's disease. The New England Journal of Medicine. 327: 1589-90. PMID 1435887 DOI: 10.1056/NEJM199211263272209 |
0.308 |
|
| 1992 |
Gasser T, Fahn S, Breakefield XO. The autosomal dominant dystonias. Brain Pathology (Zurich, Switzerland). 2: 297-308. PMID 1341964 DOI: 10.1111/J.1750-3639.1992.Tb00707.X |
0.308 |
|
| 1991 |
Chan J, Brin MF, Fahn S. Idiopathic cervical dystonia: clinical characteristics. Movement Disorders : Official Journal of the Movement Disorder Society. 6: 119-26. PMID 2057004 DOI: 10.1002/mds.870060206 |
0.307 |
|
| 1991 |
Saint Hilaire MH, Burke RE, Bressman SB, Brin MF, Fahn S. Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology. 41: 216-22. PMID 1992364 DOI: 10.1212/Wnl.41.2_Part_1.216 |
0.318 |
|
| 1991 |
Nygaard TG, Marsden CD, Fahn S. Dopa-responsive dystonia: long-term treatment response and prognosis. Neurology. 41: 174-81. PMID 1899474 DOI: 10.1212/WNL.41.2_Part_1.174 |
0.344 |
|
| 1991 |
Przedborski S, Levivier M, Kostic V, Jackson-Lewis V, Dollison A, Gash DM, Fahn S, Cadet JL. Sham transplantation protects against 6-hydroxydopamine-induced dopaminergic toxicity in rats: behavioral and morphological evidence. Brain Research. 550: 231-8. PMID 1832076 DOI: 10.1016/0006-8993(91)91323-S |
0.345 |
|
| 1991 |
Eidelberg D, Dhawan V, Moeller JR, Sidtis JJ, Ginos JZ, Strother SC, Cederbaum J, Greene P, Fahn S, Powers JM. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry. 54: 856-62. PMID 1744638 DOI: 10.1136/jnnp.54.10.856 |
0.32 |
|
| 1990 |
Nygaard TG, Trugman JM, de Yebenes JG, Fahn S. Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American family. Neurology. 40: 66-9. PMID 2296384 DOI: 10.1212/WNL.40.1.66 |
0.313 |
|
| 1990 |
Fahn S, Burke R, Stern Y. Antimuscarinic drugs in the treatment of movement disorders. Progress in Brain Research. 84: 389-97. PMID 2267310 DOI: 10.1016/S0079-6123(08)60922-X |
0.423 |
|
| 1990 |
Giladi N, Burke RE, Kostic V, Przedborski S, Gordon M, Hunt A, Fahn S. Hemiparkinsonism-hemiatrophy syndrome: clinical and neuroradiologic features. Neurology. 40: 1731-4. PMID 2234429 DOI: 10.1212/Wnl.40.11.1731 |
0.319 |
|
| 1990 |
Eidelberg D, Moeller JR, Dhawan V, Sidtis JJ, Ginos JZ, Strother SC, Cedarbaum J, Greene P, Fahn S, Rottenberg DA. The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies. Movement Disorders : Official Journal of the Movement Disorder Society. 5: 203-13. PMID 2117706 DOI: 10.1002/mds.870050304 |
0.329 |
|
| 1989 |
Blitzer A, Brin MF, Greene PE, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. The Annals of Otology, Rhinology, and Laryngology. 98: 93-7. PMID 2916831 DOI: 10.1177/000348948909800202 |
0.309 |
|
| 1989 |
Fahn S. Clinical variants of idiopathic torsion dystonia. Journal of Neurology, Neurosurgery, and Psychiatry. 96-100. PMID 2666583 DOI: 10.1136/jnnp.52.Suppl.96 |
0.308 |
|
| 1989 |
Fahn S. The history of parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. S2-10. PMID 2657407 DOI: 10.1002/MDS.870040502 |
0.393 |
|
| 1989 |
Burke RE, Kang UJ, Jankovic J, Miller LG, Fahn S. Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 157-75. PMID 2567492 DOI: 10.1002/Mds.870040208 |
0.328 |
|
| 1989 |
Kang UJ, Fahn S, Schwarz H, Shoulson I, Vallejos H, Goldman J. Case 1, 1989: juvenile-onset parkinsonism, dystonia, and pyramidal tract signs. Movement Disorders : Official Journal of the Movement Disorder Society. 4: 363-70. PMID 2530440 DOI: 10.1002/Mds.870040414 |
0.335 |
|
| 1988 |
Blitzer A, Brin MF, Fahn S, Lovelace RE. Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases. The Laryngoscope. 98: 636-40. PMID 3374239 DOI: 10.1288/00005537-198806000-00012 |
0.316 |
|
| 1988 |
Mayeux R, Stern Y, Rosenstein R, Marder K, Hauser A, Cote L, Fahn S. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Archives of Neurology. 45: 260-2. PMID 3341950 DOI: 10.1001/Archneur.1988.00520270034017 |
0.713 |
|
| 1988 |
de Yebenes JG, Brin MF, Mena MA, De Felipe C, del Rio RM, Bazan E, Martinez A, Fahn S, Del Rio J, Vazquez A. Neurochemical findings in neuroacanthocytosis. Movement Disorders : Official Journal of the Movement Disorder Society. 3: 300-12. PMID 2905427 DOI: 10.1002/mds.870030404 |
0.319 |
|
| 1988 |
Shoulson I, Fahn S, Langston JW. Symposium on the Etiology, Pathogenesis, and Prevention of Parkinson's Disease Archives of Neurology. 45: 807-811. DOI: 10.1001/ARCHNEUR.1988.00520310125030 |
0.384 |
|
| 1986 |
Burke RE, Brin MF, Fahn S, Bressman SB, Moskowitz C. Analysis of the clinical course of non-Jewish, autosomal dominant torsion dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 163-78. PMID 3504242 DOI: 10.1002/mds.870010302 |
0.311 |
|
| 1986 |
Shale H, Fahn S, Mayeux R. Tics in a patient with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 1: 79-83. PMID 3504234 DOI: 10.1002/mds.870010111 |
0.611 |
|
| 1986 |
Mayeux R, Stern Y, Herman A, Greenbaum L, Fahn S. Correlates of early disability in Huntington's disease. Annals of Neurology. 20: 727-31. PMID 2949692 DOI: 10.1002/Ana.410200613 |
0.624 |
|
| 1985 |
Fahn S. Wilson's Disease Neurology. 35: 624-624. DOI: 10.1212/WNL.35.4.624 |
0.327 |
|
| 1984 |
Fahn S, Bressman SB. Should levodopa therapy for Parkinsonism be started early or late? Evidence against early treatment. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 11: 200-5. PMID 6713318 DOI: 10.1017/S0317167100046412 |
0.316 |
|
| 1984 |
Stern Y, Mayeux R, Ilson J, Fahn S, Cote L. Pergolide therapy for Parkinson's disease: neurobehavioral changes. Neurology. 34: 201-4. PMID 6538009 DOI: 10.1212/Wnl.34.2.201 |
0.64 |
|
| 1984 |
Reches A, Wagner HR, Barkai AI, Jackson V, Yablonskaya-Alter E, Fahn S. Electroconvulsive treatment and haloperidol: effects on pre- and postsynaptic dopamine receptors in rat brain. Psychopharmacology. 83: 155-8. PMID 6431465 DOI: 10.1007/BF00429725 |
0.301 |
|
| 1984 |
Fahn S. Parkinson-Specific Motor and Mental Disorders-Role of the Pallidum: Pathophysiological, Biochemical, and Therapeutic Aspects (Advances in Neurology, Vol. 40) Neurology. 34: 846-846. DOI: 10.1212/WNL.34.6.846 |
0.303 |
|
| 1984 |
Fahn S. Alzheimer's Disease: A Report of Progress in Research Neurology. 34: 138-138. DOI: 10.1212/WNL.34.1.138-a |
0.313 |
|
| 1983 |
Ilson J, Fahn S, Mayeux R, Cote LJ, Snider SR. Pergolide treatment in parkinsonism. Advances in Neurology. 37: 85-94. PMID 6858780 |
0.504 |
|
| 1983 |
Jiang D, Reches A, Fahn S. Normal erythrocyte uptake of L-DOPA in Parkinson's, Huntington's, and related diseases. Neurology. 33: 793-6. PMID 6221201 DOI: 10.1212/WNL.33.6.793 |
0.345 |
|
| 1982 |
Matison R, Mayeux R, Rosen J, Fahn S. "Tip-of-the-tongue" phenomenon in Parkinson disease. Neurology. 32: 567-70. PMID 7200216 DOI: 10.1212/WNL.32.5.567 |
0.588 |
|
| 1982 |
Mayeux R, Fahn S. Paroxysmal dystonic choreoathetosis in a patient with familial ataxia. Neurology. 32: 1184-6. PMID 6889704 DOI: 10.1212/Wnl.32.10.1184 |
0.53 |
|
| 1982 |
Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, Ilson J. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology. 32: 1335-46. PMID 6128697 DOI: 10.1212/WNL.32.12.1335 |
0.311 |
|
| 1981 |
Burke RE, Fahn S, Mayeux R, Weinberg H, Louis K, Willner JH. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. Neurology. 31: 1022-5. PMID 6115336 DOI: 10.1212/Wnl.31.8.1022 |
0.552 |
|
| 1980 |
Mayeux R, Hunter S, Fahn S. More on myoclonus in Alzheimer disease. Annals of Neurology. 8: 200. PMID 7425576 DOI: 10.1002/ana.410080214 |
0.548 |
|
| 1980 |
Fahn S, Mayeux R. Unilateral Parkinson's disease and contralateral tardive dyskinesia: a unique case with successful therapy that may explain the pathophysiology of these two disorders. Journal of Neural Transmission. Supplementum. 179-85. PMID 6933220 |
0.559 |
|
| 1980 |
Fahn S. Huntington's Disease. Advances in Neurology, Vol. 23 Neurology. 30: 793-793. DOI: 10.1212/WNL.30.7.793-a |
0.343 |
|
| 1979 |
Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barrett RE. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology. 29: 1253-60. PMID 573405 DOI: 10.1212/WNL.29.9_Part_1.1253 |
0.337 |
|
| 1979 |
Fahn S, Cote LJ, Snider SR, Barrett RE, Isgreen WP. The role of bromocriptine in the treatment of parkinsonism. Neurology. 29: 1077-83. PMID 572493 DOI: 10.1212/WNL.29.8.1077 |
0.305 |
|
| 1979 |
FAHN S. Parkinson's Disease: A Guide for Patient and Family Neurology. 29: 532-532. DOI: 10.1212/WNL.29.4.532-B |
0.377 |
|
| 1979 |
MAYEUX R, FAHN S. Cerebral arteritis associated with ulcerative colitis Neurology. 29: 425-425. DOI: 10.1212/WNL.29.3.425-a |
0.487 |
|
| 1978 |
Mayeux R, Fahn S. Strokes and ulcerative colitis. Neurology. 28: 571-4. PMID 565888 DOI: 10.1212/Wnl.28.6.571 |
0.526 |
|
| 1978 |
FAHN S, CALNE DB. Need for uncombined carbidopa to treat parkinsonism Neurology. 28: 1070-1070. DOI: 10.1212/WNL.28.10.1070 |
0.37 |
|
| 1976 |
Snider SR, Fahn S, Isgreen WP, Cote LJ. Primary sensory symptoms in parkinsonism. Neurology. 26: 423-9. PMID 944393 DOI: 10.1212/WNL.26.5.423 |
0.313 |
|
| 1975 |
Fahn S, Isgreen WP. Long-term evaluation of amantadine and levodopa combination in parkinsonism by double-blind corssover analyses. Neurology. 25: 695-700. PMID 807869 DOI: 10.1212/WNL.25.8.695 |
0.338 |
|
| 1974 |
Earnest MP, Fahn S, Karp JH, Rowland LP. Normal pressure hydrocephalus and hypertensive cerebrovascular disease. Archives of Neurology. 31: 262-6. PMID 4414845 DOI: 10.1001/Archneur.1974.00490400076009 |
0.607 |
|
| 1973 |
Brait K, Fahn S, Schwarz GA. Sporadic and familial parkinsonism and motor neuron disease. Neurology. 23: 990-1002. PMID 4737691 DOI: 10.1212/WNL.23.9.990 |
0.326 |
|
| 1964 |
ROWLAND LP, FAHN S, HIRSCHBERG E, HARTER DH. MYOGLOBINURIA. Archives of Neurology. 10: 537-62. PMID 14130414 |
0.503 |
|
| 1963 |
FAHN S, SCHOTLAND DL, ROWLAND LP. MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE. Transactions of the American Neurological Association. 88: 145-7. PMID 14272202 |
0.564 |
|
| 1963 |
ROWLAND LP, FAHN S, SCHOTLAND DL. MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE. Archives of Neurology. 9: 325-42. PMID 14055781 DOI: 10.1001/archneur.1963.00460100013001 |
0.613 |
|
| Show low-probability matches. |
